Kolexia
Benotmane Ilies
Néphrologie
Hôpital Civil
Strasbourg, France
96 Activités
163 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Maladies du rein Maladies transmissibles Infections à coronavirus Pneumopathie virale Syndrome de libération de cytokines Vaccine Infections à polyomavirus Virémie

Industries

Biotest
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
Astellas
3 collaboration(s)
Dernière en 2022
Novartis
1 collaboration(s)
Dernière en 2020

Dernières activités

Neutralizing antibodies as key players in preventing BK polyomavirus replication: Insights from bench to bedside.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   09 février 2024
Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplant.
JAMA   21 novembre 2023
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Transplantation   20 juillet 2023
Torque teno virus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients.
Journal of medical virology   07 juillet 2023
Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding.
The Journal of infection   09 février 2023
Use of tecovirimat for the treatment of mpox infection in a kidney transplant recipient.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   08 février 2023
Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients.
Frontiers in immunology   04 octobre 2022
A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
Kidney international   13 août 2022
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
Journal of personalized medicine   05 juillet 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   30 juin 2022